Efficacy and safety of nivolumab (Nivo) + ipilimumab (Ipi) in patients (pts) with recurrent/metastatic (R/M) cervical cancer: Results from CheckMate 358

R. Wendel Naumann, Ana Oaknin, Tim Meyer, José M. López-Picazo, Christopher D. Lao, Yu Jeong Bang, Valentina Boni, William H. Sharfman, J.C. Park, Lot A. Devriese,

Annals of Oncology · 2019 · 91 citations · 0 references

DOIFull text

Open access

Concepts